Filter
346
Filtered Results: 346
Text search:
Sauli,
E.
et
al.
Featured
Recommendations
37
New Publications
68
Language
Document type
No document type
150
Studies & Reports
101
Guidelines
46
Manuals
19
Strategic & Response Plan
10
Fact sheets
9
Training Material
8
Situation Updates
2
Infographics
1
Countries / Regions
Global
30
Middle East and North Africa
13
Syria
10
Venezuela
7
Russia
7
Yemen
7
Africa
6
Colombia
5
Mozambique
5
Latin America and the Carribbean
5
Saudi Arabia
5
Sudan
5
Nigeria
4
Burkina Faso
4
Cambodia
4
Jordan
4
Germany
4
Western and Central Europe
4
Lebanon
4
South Africa
4
Brazil
4
Iraq
4
Pakistan
4
Mexico
3
Afghanistan
3
Peru
3
Philippines
3
Asia
3
Tanzania
3
Eastern Europe
3
Palestine
3
Libya
3
South Sudan
3
Somalia
3
Nepal
2
Kenya
2
China
2
Iran
2
Senegal
2
Malawi
2
Morocco
2
Qatar
2
Congo, Democratic Republic of
2
West and Central Africa
2
Paraguay
2
Tunisia
2
Portugal
2
East and Southern Africa
2
Uganda
2
Egypt
2
Ethiopia
2
Mali
2
Angola
2
Indonesia
2
India
2
Thailand
1
Lesotho
1
Turkey
1
Ghana
1
Benin
1
Sierra Leone
1
Rwanda
1
Albania
1
Canada
1
Laos
1
Niger
1
Mauritania
1
Armenia
1
Haiti
1
Guinea-Bissau
1
Spain
1
Israel
1
Argentina
1
Bangladesh
1
Vietnam
1
Papua New Guinea
1
Djibouti
1
Romania
1
Greece
1
Georgia
1
Central African Republic
1
Chad
1
Botswana
1
Liberia
1
Ecuador
1
Myanmar / Burma
1
Authors & Publishers
Publication Years
Category
Countries
89
Clinical Guidelines
44
Public Health
28
Women & Child Health
21
Key Resources
9
Capacity Building
6
Pharmacy & Technologies
4
Toolboxes
COVID-19
52
Mental Health
39
Planetary Health
19
NTDs
16
TB
15
AMR
15
Rapid Response
14
Disability
13
HIV
11
Refugee
10
Health Financing Toolbox
10
NCDs
9
Conflict
9
Global Health Education
6
Caregiver
5
Pharmacy
5
Natural Hazards
3
Cholera
3
Ebola
3
Social Ethics
3
Specific Hazards
2
Polio
2
Mapping Children on the Move
recommended
In reviewing State Parties report on the implementation of the Charter, the Committee has identified children on the move as an emerging child protection issue in African, and therefore commissioned a study in view of making recommendations to tackle the problem in Member States. The Committee obse...
Health, Rights and Drugs
recommended
Harm Reducation, Decriminalization and Zero Discrimination for People who use Drugs
Dignity in Mental Health
At present at least 2.2 billion people around the world have a vision impairment, of whom at least 1 billion have a vision impairment that could have been prevented or is yet to be addressed. The world faces considerable challenges in terms of eye care, including inequalities in the coverage and qua...
The booklet starts with a general overview of how illicit drugs and the environment are linked within the bigger picture of the Sustainable Development Goals, climate change and environmental sustainability. It highlights direct and indirect linkages and gives examples of the significant local and i...
This is a case-ascertained prospective investigation of all identified health care contacts working in a health care facility in which a laboratory confirmed 2019-nCoV infected patient (see 2.2 Study population) receives care. Note that this study can be done in health care facilities at all 3 level...
16.7.2021
The current document is anupdate of the guidelines developed by the EUCAST subcommittee on detection of resistance mechanisms. The EUCAST Steering Committee has carried out the current update. The document has been developed mainly for routine use in clinical laboratories and doesnot cover technical...
This interim guidance is for LTCF managers and corresponding infection prevention and control (IPC) focal persons in LTCF and updates the guidance published in March 2020. The objective of this document is to provide guidance on IPC in LTCFs in the context of COVID-19 to 1) prevent COVID-19-virus fr...
23 December 2020 This document summarizes WHO recommendations for the rational use of personal protective equipment (PPE) in health care settings and temporary strategies during acute supply shortages. This document also contains 2 Annex sections describing updated PPE use recommendations for health...
10 May 2021
This scientific brief replaces the WHO Scientific Brief entitled “’Immunity passports’ in the context of COVID-19”, published 24 April 2020.
This update is focused on what is currently understood about SARS-CoV-2 immunity from natural infection. More information about considera...
First published in 2020, this toolkit is intended for clinicians working in acute care, managing adult and paediatric patients with acute respiratory infection, including severe pneumonia, acute respiratory distress syndrome, sepsis and septic shock. The main objective is to provide key tools for us...
21 August 2020
This guidance provides specific considerations for the use of non-medical masks, also known as fabric masks, by children as a means for source control in the context of the current COVID-19 pandemic. It also advises on the use of medical masks for children under certain conditions.
Whole-genome sequencing (WGS) provides a vast amount of information and the highest possible resolution for pathogen subtyping. The application of WGS for global surveillance can provide information on the early emergence and spread of AMR and further inform timely policy development on AMR control....
Prevention, identification and management of health worker infection in the context of COVID-19
recommended
This document provides interim guidance on the prevention, identification and management of health worker infection in the context of COVID-19. It is intended for occupational health departments, infection prevention and control departments or focal points, health facility administrators and public ...
With this quick reference guide, providers can easily recognize diseases and side effects related to climate change, implement appropriate management and provide guidance to exposed populations, provide up-to-date information on the relationship between the adverse effects of certain drugs and the w...
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform...
Vaccines 2021, 9(2), 160; https://doi.org/10.3390/vaccines9020160
